These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38070841)

  • 1. Natural killer cells at the forefront of cancer immunotherapy with immune potency, genetic engineering, and nanotechnology.
    Pan W; Tao T; Qiu Y; Zhu X; Zhou X
    Crit Rev Oncol Hematol; 2024 Jan; 193():104231. PubMed ID: 38070841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prospect of genetically engineering natural killer cells for cancer immunotherapy.
    Poon AYC; Sugimura R
    Biol Open; 2022 Dec; 11(12):. PubMed ID: 36445164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
    Kim N; Kim HS
    Front Immunol; 2018; 9():2041. PubMed ID: 30250471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell engineering - a new hope for cancer immunotherapy.
    Lin CY; Gobius I; Souza-Fonseca-Guimaraes F
    Semin Hematol; 2020 Oct; 57(4):194-200. PubMed ID: 33256912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric antigen receptor (CAR) natural killer (NK)-cell therapy: leveraging the power of innate immunity.
    Rafei H; Daher M; Rezvani K
    Br J Haematol; 2021 Apr; 193(2):216-230. PubMed ID: 33216984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering Natural Killer Cells for Cancer Immunotherapy.
    Rezvani K; Rouce R; Liu E; Shpall E
    Mol Ther; 2017 Aug; 25(8):1769-1781. PubMed ID: 28668320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy.
    Shaver KA; Croom-Perez TJ; Copik AJ
    Front Immunol; 2021; 12():679117. PubMed ID: 33995422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Natural Killer Cells for Tumor Immunotherapy.
    Zhang C; Hu Y; Shi C
    Front Immunol; 2020; 11():60. PubMed ID: 32140153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities.
    Hu W; Wang G; Huang D; Sui M; Xu Y
    Front Immunol; 2019; 10():1205. PubMed ID: 31214177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application and prospect of immune checkpoint inhibitors for CAR-NK cell in tumor immunotherapy.
    Yang K; Zhao Y; Sun G; Zhang X; Cao J; Shao M; Liang X; Wang L
    Front Immunol; 2022; 13():1081546. PubMed ID: 36741400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell-based strategies for immunotherapy of cancer.
    Vaněk O; Kalousková B; Abreu C; Nejadebrahim S; Skořepa O
    Adv Protein Chem Struct Biol; 2022; 129():91-133. PubMed ID: 35305726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driving natural killer cell-based cancer immunotherapy for cancer treatment: An arduous journey to promising ground.
    Jiang D; Zhang J; Mao Z; Shi J; Ma P
    Biomed Pharmacother; 2023 Sep; 165():115004. PubMed ID: 37352703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell.
    Lin C; Zhang J
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):200-215. PubMed ID: 29378229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond.
    Shin E; Bak SH; Park T; Kim JW; Yoon SR; Jung H; Noh JY
    Front Immunol; 2023; 14():1192907. PubMed ID: 37539051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells in antitumour adoptive cell immunotherapy.
    Laskowski TJ; Biederstädt A; Rezvani K
    Nat Rev Cancer; 2022 Oct; 22(10):557-575. PubMed ID: 35879429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy.
    Cao Y; Wang X; Jin T; Tian Y; Dai C; Widarma C; Song R; Xu F
    Signal Transduct Target Ther; 2020 Oct; 5(1):250. PubMed ID: 33122640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonviral genome engineering of natural killer cells.
    Robbins GM; Wang M; Pomeroy EJ; Moriarity BS
    Stem Cell Res Ther; 2021 Jun; 12(1):350. PubMed ID: 34134774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Engineering of Natural Killer Cells for Enhanced Antitumor Function.
    Mantesso S; Geerts D; Spanholtz J; Kučerová L
    Front Immunol; 2020; 11():607131. PubMed ID: 33391277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killers 2.0: NK cell therapies at the forefront of cancer control.
    Hodgins JJ; Khan ST; Park MM; Auer RC; Ardolino M
    J Clin Invest; 2019 Sep; 129(9):3499-3510. PubMed ID: 31478911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer.
    Rezvani K; Rouce RH
    Front Immunol; 2015; 6():578. PubMed ID: 26635792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.